MX2022015230A - Metodos y usos zonal y dirigido para el tratamiento de un trastorno de migra?a. - Google Patents
Metodos y usos zonal y dirigido para el tratamiento de un trastorno de migra?a.Info
- Publication number
- MX2022015230A MX2022015230A MX2022015230A MX2022015230A MX2022015230A MX 2022015230 A MX2022015230 A MX 2022015230A MX 2022015230 A MX2022015230 A MX 2022015230A MX 2022015230 A MX2022015230 A MX 2022015230A MX 2022015230 A MX2022015230 A MX 2022015230A
- Authority
- MX
- Mexico
- Prior art keywords
- individual
- areas
- layer located
- treating
- head region
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 208000019695 Migraine disease Diseases 0.000 title abstract 2
- 206010027599 migraine Diseases 0.000 title abstract 2
- 108030001720 Bontoxilysin Proteins 0.000 abstract 2
- 229940053031 botulinum toxin Drugs 0.000 abstract 2
- HAPOVYFOVVWLRS-UHFFFAOYSA-N ethosuximide Chemical compound CCC1(C)CC(=O)NC1=O HAPOVYFOVVWLRS-UHFFFAOYSA-N 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
- 230000002123 temporal effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Abstract
La presente memoria descriptiva describe métodos y usos para tratar un trastorno de migraña. El método que se da a conocer comprende la administración extramuscular de una toxina botulínica a un individuo en una o más áreas de una capa fronto-fascial ubicada en una región frontal de la cabeza del individuo, una o más áreas de una capa temporoparietal-fascial ubicada en una región temporal de la cabeza del individuo, y una o más áreas de una capa occipito-fascial ubicada en una región occipital de la cabeza del individuo. Los métodos y usos descritos comprenden además la administración extramuscular de una toxina botulínica a uno o más puntos de salida de nervio y/o una o más ubicaciones subcutáneas en la cabeza y el cuello, así como a uno o más sitios de una aponeurosis epicraneal. Los métodos y usos descritos comprenden además la administración intramuscular de una toxina botulínica en uno o más lugares dentro del músculo Splenius Capitus izquierdo y derecho, los músculos maseteros izquierdo y derecho, los músculos trapecio izquierdo y derecho, o cualquier combinación de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063034215P | 2020-06-03 | 2020-06-03 | |
| PCT/US2021/035736 WO2021247890A1 (en) | 2020-06-03 | 2021-06-03 | Zonal and targeted methods and uses for treating a migraine disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022015230A true MX2022015230A (es) | 2023-01-04 |
Family
ID=78816779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022015230A MX2022015230A (es) | 2020-06-03 | 2021-06-03 | Metodos y usos zonal y dirigido para el tratamiento de un trastorno de migra?a. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210379166A1 (es) |
| EP (1) | EP4161540A1 (es) |
| JP (1) | JP2023528453A (es) |
| CN (1) | CN116096399A (es) |
| AU (1) | AU2021284378A1 (es) |
| CA (1) | CA3181130A1 (es) |
| MX (1) | MX2022015230A (es) |
| WO (1) | WO2021247890A1 (es) |
| ZA (1) | ZA202213014B (es) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8734810B2 (en) * | 2003-10-29 | 2014-05-27 | Allergan, Inc. | Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| US9078892B2 (en) * | 2004-02-26 | 2015-07-14 | Allergan, Inc. | Methods for treating pain and for treating a medication overuse disorder |
| US8617571B2 (en) * | 2008-04-03 | 2013-12-31 | Allergan, Inc. | Suture line administration technique using botulinum toxin |
| US8491917B1 (en) * | 2012-03-12 | 2013-07-23 | William J. Bender | Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the head |
| KR20180058777A (ko) * | 2015-09-24 | 2018-06-01 | 테바 파마슈티컬스 인터내셔널 게엠베하 | (지속성) 외상후 두통의 예방, 치료 및 감소 |
| EP3600385A4 (en) * | 2017-03-22 | 2021-04-07 | Bonti, Inc. | BOTULINUM NEUROTOXINS FOR THE TREATMENT OF TRAUMATIC INJURIES |
-
2021
- 2021-06-03 EP EP21817229.4A patent/EP4161540A1/en active Pending
- 2021-06-03 US US17/338,388 patent/US20210379166A1/en active Pending
- 2021-06-03 CA CA3181130A patent/CA3181130A1/en active Pending
- 2021-06-03 AU AU2021284378A patent/AU2021284378A1/en active Pending
- 2021-06-03 MX MX2022015230A patent/MX2022015230A/es unknown
- 2021-06-03 WO PCT/US2021/035736 patent/WO2021247890A1/en unknown
- 2021-06-03 CN CN202180056839.5A patent/CN116096399A/zh active Pending
- 2021-06-03 JP JP2022574396A patent/JP2023528453A/ja active Pending
-
2022
- 2022-11-30 ZA ZA2022/13014A patent/ZA202213014B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4161540A1 (en) | 2023-04-12 |
| CA3181130A1 (en) | 2021-12-09 |
| JP2023528453A (ja) | 2023-07-04 |
| US20210379166A1 (en) | 2021-12-09 |
| WO2021247890A1 (en) | 2021-12-09 |
| ZA202213014B (en) | 2024-03-27 |
| AU2021284378A1 (en) | 2023-01-19 |
| CN116096399A (zh) | 2023-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wheeler | Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension | |
| Blitzer et al. | Botulinum toxin: basic science and clinical uses in otolaryngology | |
| Ommaya et al. | Tolerances for cerebral concussion from head impact and whiplash in primates | |
| CA2424242A1 (en) | Methods for treating muscle injuries | |
| US8420106B1 (en) | Extramuscular treatment of traumatic-induced migraine headache | |
| Laskawi | The use of botulinum toxin in head and face medicine: an interdisciplinary field | |
| NZ603717A (en) | Suture line administration technique using botulinum toxins | |
| BR0309888A (pt) | Tratamento intracraniano de distúrbios neuropsiquiátricos por neurotoxinas clostridiais tal como a toxina da botulina | |
| ZA202213014B (en) | Zonal and targeted methods and uses for treating a migraine disorder | |
| MX2023003993A (es) | Tratamiento de trastornos bipolares y psicosis con clorhidrato de dexmedetomidina. | |
| US8722060B2 (en) | Method of treating vertigo | |
| Kruegel et al. | Botulinum toxin: a noninvasive option for the symptomatic treatment of salivary gland stenosis—a case report | |
| Kiralp et al. | Comparison of low intensity laser therapy and trigger point injection in the management of myofascial pain syndrome | |
| US7270826B2 (en) | Methods of using Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion) | |
| Truong et al. | Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations | |
| Balikian et al. | Primary and adjunctive uses of botulinum toxin type A in the periorbital region | |
| WO2022067223A3 (en) | Cannabis plant derived extracellular vesicles and therapeutic methods using the same | |
| Peng | Masseter Hypertrophy: Toxin Treatment Techniques, Causes of Complications, and Prevention | |
| Pérez et al. | Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior | |
| Keir | Botulinum toxin—physiology and applications in head and neck disorders | |
| BRPI0409744A (pt) | emprego de uma neurotoxina de botulinum para aliviar vários distúrbios | |
| Bono et al. | Botulinum toxin is effective in myoclonus secondary to peripheral nerve injury | |
| DE102020001038A1 (de) | Botulinum zur gewichtsreduktion | |
| IL273435B1 (en) | Botulinum neurotoxin A subtype 6 and methods of pharmacological use | |
| Barbano | Anatomic principles for botulinum toxin injection |